![](/cdn/assets/images/search/clock.png)
We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
---|---|---|---|---|---|
Futura Medical Plc | LSE:FUM | London | Ordinary Share | GB0033278473 | ORD 0.2P |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
0.225 | 0.67% | 33.825 | 33.50 | 34.15 | 35.95 | 33.50 | 35.00 | 494,358 | 16:35:20 |
Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
---|---|---|---|---|---|
Pharmaceutical Preparations | 3.1M | -6.51M | -0.0216 | -15.51 | 101.29M |
Date | Subject | Author | Discuss |
---|---|---|---|
15/12/2022 15:51 | Interesting to see Lombard at 27%. Should keep management focused! | ![]() waterloo01 | |
15/12/2022 15:18 | If they get a 10% market share of the ED market Thats $500 million a year in sales You can therefore easily see why Fum will be worth well over $ One billion The Americans are in negotiations and they are buying shares on the other side of the pond They know a good thing when they see it | ![]() j777j | |
15/12/2022 14:54 | Yea oh dear indeed! LOL JoeStalin - 30 Sep 2019 - 10:07:37 - 5937 of 10774 FUTURA a winner for 2015 - says it all! JoeStalin - 18 Jul 2018 - 09:00:46 - 4354 of 10775 'jam tomorrow' is a very easy promise to make. JoeStalin - 22 Jun 2018 - 14:12:24 - 4288 of 10775 What's another year after all? At FUM, time is measured in decades. JoeStalin - 25 Apr 2018 - 16:07:34 - 4147 of 10775 There seems to be an unlimited number of ways of saying "Jam tomorrow". JoeStalin - 21 Mar 2018 - 13:50:44 - 3985 of 10775 A lifestyle company, but not for the shareholders. | lbo | |
15/12/2022 14:51 | Oh dear, indeed. | ![]() joestalin | |
15/12/2022 14:11 | LBO possibly a BOT? I cannot believe a real person would dedicate literally his entire life to knocking one share obsessively. If he is real, he is one hell of a sad character, although I suppose someone must be paying him. Even so, a sad pointless life. | ![]() freddievas | |
15/12/2022 13:20 | LOL! ROFLMAO! | petroc | |
15/12/2022 12:54 | It’s great to see what a little help does! | ![]() hybrasil | |
15/12/2022 12:42 | BTW lbo still uses Lol!! Shows how out of touch he is lol!!!! Really Ok dear | ![]() j777j | |
15/12/2022 12:42 | Exactly what happen with Shield Therapeutics. Which from end of 2021 to today has fallen from over 50p to 7p and have now announced a fundraising at 6p. At end of August 2021 at over 43p its brokers said ˜We value STX at £631.3m or 293p/share’. Yet they fell to 7p And in November 2021 at at 37p Proactive said ˜as sales momentum starts to build, the shares should perform strongly. The company is well into the launch processâ€&trade | lbo | |
15/12/2022 12:39 | Multibagger right in front of your eyes | ![]() j777j | |
15/12/2022 11:56 | James Barder has previously stated he would not rule out a takeover for the co by much larger player. The US changes everything as that makes it much more feasable approaching FDA marketing approval Watch this space | ![]() j777j | |
15/12/2022 11:51 | Trinity Delta " with the US opportunity alone more than underpinning the current share price." Multibagger right in front of your eyes | ![]() j777j | |
15/12/2022 11:11 | What odds another ‘innovative deal’ for funding is on the way for the USA! LOL Market Cap is now over £160m for a company with Zero revenues and no enforceable patent on a placebo gel just made of alcohol, water, glycol and Carbopol! Death-Spiral Convertible Financier Has a Lot of Fun | lbo | |
15/12/2022 11:05 | If we break out above 60p this month (this week?!) it will be VERY interesting to learn what Zak Mir's new target will be. | broomrigg | |
15/12/2022 11:03 | SOS100......lollllll | broomrigg |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions